Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
Study finds low vaccination rates among teen survivors.
Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
After the deaths of her sister and mother from cancer and a bout with osteosarcoma as a teenager, Court Simmons vowed to “do something amazing” with her life. Her goal is to be a pediatric oncology nurse.
by Lindsey Konkel
Neoadjuvant therapy may be an option.
by Dara Chadwick
Successful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
Advocacy In Action
Lori Marx-Rubiner and AnneMarie Ciccarella met on social media and grew close through their cancer research advocacy.
by Sue Rochman
More children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments.
by Cameron Walker
During her husband's treatment for metastatic prostate cancer, Jan Manarite learned what questions to ask. Now she shares what she learned with others.
Breast cancer risk factor may be overlooked.
by Kendall K. Morgan
Stock your bag with these useful items before your next infusion session.
by Jamie L. Schwachter
An updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
AACR leaders Margaret Foti, PhD, MD (hc), Elizabeth M. Jaffee, MD, and Elaine R. Mardis, PhD, share their stories.
The FDA approves an antihormone agent to treat prostate cancer.
Women who work the night shift may have an increased risk of developing some cancers.
The Financial Toll of Cancer
donate to the AACR